Skip to main navigation Skip to search Skip to main content

Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study

    Research output: Contribution to journalArticleScientificpeer-review

    47 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)134-142
    JournalJournal of Clinical Immunology
    Volume33
    Issue number1
    DOIs
    Publication statusPublished - 2013
    Publication typeA1 Journal article-refereed

    Keywords

    • celiac disease
    • gliadin
    • inhibitor
    • small intestine
    • transglutaminase 2

    Publication forum classification

    • Publication forum level 1

    Cite this